Wilson Asset Management International PTY Ltd. grew its stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 18.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 757,032 shares of the company's stock after buying an additional 115,880 shares during the period. Avantor accounts for approximately 4.7% of Wilson Asset Management International PTY Ltd.'s holdings, making the stock its 8th biggest holding. Wilson Asset Management International PTY Ltd. owned approximately 0.11% of Avantor worth $19,584,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of AVTR. Versant Capital Management Inc lifted its stake in shares of Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company's stock worth $25,000 after acquiring an additional 1,102 shares in the last quarter. Blue Trust Inc. boosted its stake in shares of Avantor by 1,830.3% during the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company's stock valued at $31,000 after buying an additional 1,391 shares during the last quarter. UMB Bank n.a. acquired a new stake in shares of Avantor during the third quarter worth approximately $49,000. Nisa Investment Advisors LLC increased its position in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock worth $53,000 after purchasing an additional 835 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of Avantor by 89.9% in the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company's stock valued at $70,000 after purchasing an additional 1,285 shares in the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.
Avantor Stock Down 0.5 %
Shares of NYSE AVTR traded down $0.12 during mid-day trading on Tuesday, reaching $22.52. The company had a trading volume of 4,194,726 shares, compared to its average volume of 6,430,188. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.05 and a current ratio of 1.59. The company has a market capitalization of $15.30 billion, a price-to-earnings ratio of 58.03, a PEG ratio of 2.93 and a beta of 1.33. The stock has a fifty day moving average of $25.44 and a two-hundred day moving average of $24.23. Avantor, Inc. has a 12-month low of $16.63 and a 12-month high of $28.00.
Avantor (NYSE:AVTR - Get Free Report) last posted its earnings results on Friday, July 26th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.23 by $0.02. Avantor had a net margin of 5.28% and a return on equity of 12.40%. The company had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.70 billion. As a group, equities research analysts expect that Avantor, Inc. will post 1.01 EPS for the current year.
Analysts Set New Price Targets
AVTR has been the subject of several research analyst reports. Stifel Nicolaus boosted their price objective on Avantor from $27.00 to $28.00 and gave the company a "buy" rating in a report on Monday, July 29th. Wells Fargo & Company reduced their price objective on Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Monday. Morgan Stanley boosted their target price on shares of Avantor from $28.00 to $29.00 and gave the company an "overweight" rating in a research note on Monday, July 29th. Barclays reduced their price target on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research report on Friday. Finally, TD Cowen raised their target price on Avantor from $28.00 to $31.00 and gave the company a "buy" rating in a research note on Monday, July 29th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, Avantor presently has a consensus rating of "Moderate Buy" and an average target price of $27.57.
Read Our Latest Stock Analysis on AVTR
Insiders Place Their Bets
In related news, CAO Steven W. Eck sold 3,525 shares of the firm's stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the transaction, the chief accounting officer now directly owns 29,544 shares of the company's stock, valued at $740,372.64. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.50% of the company's stock.
Avantor Company Profile
(
Free Report)
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Read More
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.